S&P 500 1,316.33 -2.12
Gold$1,739.20 $13.60
Nasdaq 2,816.55 11.27
Crude Oil $99.67      $-0.20
  
 QUOTE 

Incyte Corporation (INCY)
$ 18.20 -0.36 (-1.94%) Jan 26
Experimetal Station Route 141 & Henry Clay Rd. Building E336 ,  DE  19880 , USA,
+1-302-498-6700
http://www.incyte.com
PRICES
Open Volume
18.78 3.33M
High Low
19.00 18.02
VALUATIONS
Mkt Cap Avg Volume
2229 618,800
52wk High 52wk Low
20.76 11.78
RATIOS
P/E EPS
n/a n/a
BV P/BV
-1.05 -17.33
STOCKHOLDERS
Dividend Yield
n/a n/a
Shares Inst Owner
122.48
 PERFORMANCE 

You need to upgrade your Flash Player
Chart Type: Line - Basic Comparison OHLC Candlestick Smooth
 ANNUAL EARNINGS 

You need to upgrade your Flash Player
 QUARTERLY EARNINGS (EPS) 

You need to upgrade your Flash Player
 
 SUMMARIES CALENDARS REPORTS 

Financial Summary (In millions of USD)
  20032004200520062007200820092010
Income statement
Total Revenue $41.20$14.15$7.85$27.64$34.44$3.92$9.27$169.88
Operating Income $-149.35$-148.85$-100.78$-76.86$-85.28$-159.29$-179.79$10.06
Net Income $-166.46$-164.82$-103.04$-74.17$-86.88$-178.92$-211.87$-31.85
Balance Sheet
Total Assets $379.55$516.92$374.11$353.60$275.69$232.39$232.39$712.39
Total Equity $154.33$78.52$-19.40$-84.91$-159.52$-220.75$-220.75$-102.38
Total Liabilities $225.21$438.40$393.50$438.51$435.21$453.14$453.14$814.77
Cash Flow
Operating $-118.33$-114.67$-101.87$-50.37$-92.69$-140.86$-140.86$12.36
Investing $126.35$-77.16$15.53$26.04$170.36$105.89$105.89$16.45
Financing $-1.17$294.24$-34.35$31.70$12.32$104.88$104.88$242.25
Net Cash Change $6.77$102.48$-120.69$7.37$89.99$69.91$69.91$271.06

Earning Call Calender
2010 2009 2008 2007 2006
18 February 2010
06 May 2010
05 August 2010
09 November 2010
18 February 2009
07 May 2009
30 July 2009
05 November 2009
14 February 2008
30 April 2008
30 July 2008
06 November 2008
03 May 2007
12 June 2007
21 June 2007
27 June 2007
26 July 2007
26 July 2007
01 November 2007
16 February 2006
04 May 2006
27 July 2006
02 November 2006

Earning Call Summary Transcripts
 
10K Reports Annual Reports
 
Ticker News
Biotech M&A Activity Rises, FDA Acts Catalyst
17 March 2003
 
 
Management
Executive
Title
Richard U. De Schutter
Chairman of the Board
Paul A. Friedman
President, Chief Executive Officer, Director
David C. Hastings
Chief Financial Officer, Executive Vice President
Patricia A. Schreck
Executive Vice President, General Counsel
Paula Swain
Executive Vice President - Human Resources
John A. Keller
Executive Vice President, Chief Business Officer
Brian W. Metcalf
Executive Vice President, Chief Drug Discovery Scientist
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc